ResMed reported Q1 CY2026 revenue of $1.43 billion and non-GAAP EPS of $2.86, exceeding analyst estimates on robust mask and device sales. The company announced CFO Brett Sandercock will retire on May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results